BIOBIJOU Statistics

Total Valuation

BIOBIJOU has a market cap or net worth of KRW 190.76 billion. The enterprise value is 161.29 billion.

Market Cap	190.76B
Enterprise Value	161.29B

Important Dates

The next estimated earnings date is Tuesday, March 24, 2026.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

BIOBIJOU has 15.04 million shares outstanding. The number of shares has increased by 22.47% in one year.

Current Share Class	15.04M
Shares Outstanding	15.04M
Shares Change (YoY)	+22.47%
Shares Change (QoQ)	+17.61%
Owned by Insiders (%)	8.97%
Owned by Institutions (%)	4.61%
Float	5.11M

Valuation Ratios

The trailing PE ratio is 18.79.

PE Ratio	18.79
Forward PE	n/a
PS Ratio	5.66
PB Ratio	3.00
P/TBV Ratio	3.01
P/FCF Ratio	70.47
P/OCF Ratio	64.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.78, with an EV/FCF ratio of 59.58.

EV / Earnings	18.17
EV / Sales	4.79
EV / EBITDA	14.78
EV / EBIT	15.91
EV / FCF	59.58

Financial Position

The company has a current ratio of 19.39, with a Debt / Equity ratio of 0.01.

Current Ratio	19.39
Quick Ratio	16.03
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	0.16
Interest Coverage	110.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	15.88%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BIOBIJOU has paid 2.36 billion in taxes.

Income Tax	2.36B
Effective Tax Rate	21.00%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	14,340.80
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.91
Average Volume (20 Days)	146,188

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOBIJOU had revenue of KRW 33.71 billion and earned 8.88 billion in profits. Earnings per share was 674.71.

Revenue	33.71B
Gross Profit	19.06B
Operating Income	10.14B
Pretax Income	11.24B
Net Income	8.88B
EBITDA	10.91B
EBIT	10.14B
Earnings Per Share (EPS)	674.71

Full Income Statement

Balance Sheet

The company has 29.91 billion in cash and 429.17 million in debt, giving a net cash position of 29.48 billion or 1,959.28 per share.

Cash & Cash Equivalents	29.91B
Total Debt	429.17M
Net Cash	29.48B
Net Cash Per Share	1,959.28
Equity (Book Value)	63.60B
Book Value Per Share	4,226.16
Working Capital	51.05B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.98 billion and capital expenditures -269.28 million, giving a free cash flow of 2.71 billion.

Operating Cash Flow	2.98B
Capital Expenditures	-269.28M
Free Cash Flow	2.71B
FCF Per Share	179.93

Full Cash Flow Statement

Margins

Gross margin is 56.55%, with operating and profit margins of 30.07% and 26.33%.

Gross Margin	56.55%
Operating Margin	30.07%
Pretax Margin	33.33%
Profit Margin	26.33%
EBITDA Margin	32.38%
EBIT Margin	30.07%
FCF Margin	8.03%

Dividends & Yields

BIOBIJOU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.47%
Shareholder Yield	-22.47%
Earnings Yield	4.65%
FCF Yield	1.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIOBIJOU has an Altman Z-Score of 56.07 and a Piotroski F-Score of 4.

Altman Z-Score	56.07
Piotroski F-Score	4